Table 2:
Quality-adjusted Life Year and Incremental Cost-effectiveness Ratio by Distal Radius Fracture Treatment
| Treatment Type | 12-month SF-36 Converted Health Utility (95% CI2) | QALYs3 (95% CrI5*) | Total Cost (95% CrI5*) | Incremental Costs (95% CrI5*) | ICER($/QALY)3ƚ |
|---|---|---|---|---|---|
| Casting | 0.71 (0.68 – 0.74) | 9.01 (2.61 – 12.73) | $6,837 ($5,357 – $8,078) | Lowest cost | -- |
| CRPP1 | 0.72 (0.67 – 0.77) | 9.17 (2.66 – 12.98) | $11,329 ($9,994 – $13,164) | CRPP vs. Casting: $4,492 ($3,318 – $6,497) | $28,717 |
| Ex-fix1 | 0.69 (0.65 – 0.73) | 8.81 (2.55 – 12.48) | $16,012 ($14,135 – $17,977) | Ex-fix vs. Casting: $9,175 ($7,526 – $11,388) | Dominated |
| Ex-fix vs. CRPP: $4,683 ($2,472 – $6,627) | Dominated | ||||
| VLP1 | 0.70 (0.66 – 0.74) | 8.96 (2.62 – 12.68) | $16,354 ($14,651 – $18,465) | VLP vs. casting: $9,517 ($8,062 – $11,923) | Dominated |
| VLP vs. CRPP: $5,025 ($2,993 – $7,165) | Dominated | ||||
| VLP vs. Ex-fix: $342 (−$1,847 – $2,857) | $2,117 |
1
VLP: Volar locking plate; Ex-fix: External fixation; CRPP: Closed reduction percutaneous pinning
2
CI: Confidence Interval
3
QALY: Quality-adjusted Life Year
4
ICER: Incremental Cost-effectiveness Ratio
5
CrI: Credible Interval
*
Based on model and probabilistic sensitivity analysis
ƚ
See Figure 3 for uncertainty in cost-effectiveness